Hib Vaccine Recall

  • The Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) announced a recall of 1.2 Million Doses of the Haemophilus influenzae type b (Hib) vaccine. Officials claim that all of the Hib doses are fully potent, but there is reason to believe that some of the product may be contaminated with bacteria.
  • Voluntary Recall

    The recall was voluntary, and not mandated by federal authorities. The sterility concerns emerged following routine quality-control checks that determined that some of the equipment used to process the drug did not meet company standards.

About this page

  • Page Views
    0
What is this?
No one is currently managing this page.

If you would like to apply
to be the manager of this page, please request below.

What is this?
This page currently has no vertical manager.